Philadelphia University + Thomas Jefferson University

Clinical Research

Jefferson encourages and supports research by all department staff, and has made research an integral aspect of radiation oncology training.  Department faculty, all involved in clinical or basic research, serve as advisors or mentors.  Residents are required to complete one original research project of publishable quality during their four-year training period.  Residents have 10.5 months dedicated research time during their third year of residency.  Submission of abstracts to major scientific meetings is encouraged.  In addition, residents present their research findings in the Resident Seminar.  They may also be asked to present the work at forums such as the Tumor Board and Multidisciplinary Conferences.

Meetings & Conferences

Residents are encouraged to submit oral and poster presentations to major scientific meetings and symposia. Typically, the department will fund travel to attend most conferences where the resident presents as the first author. Additionally, all PGY-4 and PGY-5 residents will attend the ASTRO national conference.

Current Resident Research Projects

Residents have typically been extremely productive in publications as well as oral and poster presentations at major national conferences.  Current resident research projects include:

  • Outcomes in combined modality treatment for duodenal adenocarcinoma
  • PET imaging in head and neck cancer staging and follow-up
  • Velcade in treatment of head and neck cancer
  • Development of MiMVista GU planning atlas
  • PET edge for treatment planning in lung cancer
  • PET edge for treatment planning in head and neck cancer
  • Deformable PET-CT treatment planning
  • Outcomes in management of craniovervical meningiomas
  • Neoadjuvant chemotherapy for esophageal cancer
  • Management and outcomes of recurrent high grade and recurrent low grade gliomas
  • Epothilone with concurrent radiation
  • Evaluation of CT vs. US planning in prostate brachytherapy
  • Outcomes with combined modality treatment of craniopharyngiomas
  • Development of pemetrexed with concurrent radiation in lung cancer
  • Outcomes with primary CNS sarcoma
  • PET vs CT lung tumor modeling
  • Spatial volumetric PET response in lung cancer
  • EGFR expression in meningiomas
  • PET imaging in followup evaluation of small cell lung cancer
  • Response of trigeminal schwannoma to radiation
  • Sunitinib with radiation in high grade gliomas
  • Sunitinib with radiation in non-high grade glioma brain tumors
  • Sorafenib with radiation in high grade gliomas
  • Sorafenib with radiation in non-high grade gliomas
  • Radiotherapy for thyroid ophthalmopathy
  • Review of Jefferson experience with stereotactic treatment of lung cancer
  • Temsirolimus and cetuximab with radiation treatment of recurrent head and neck cancer
  • Review of Jefferson experience in meningiomas
  • Review of Jefferson experience in quality of life of treatment of head and neck cancers with IMRT

Department of
Radiation Oncology

111 S. 11th Street
Philadelphia, PA 19107

Adam Dicker, MD, PhD

Letter from 
Adam Dicker

Enterprise Senior Vice President, Chair and Professor, Department of Radiation Oncology

Professor, Department of Pharmacology & Experimental Therapeutics

Director, Jefferson Center for Digital Health & Data Science

Robert Den, MD

Robert Den, MD
Associate Professor, Departments of Radiation Oncology, Urology and Cancer Biology

Program Director, Radiation Oncology Medical Residency

Director, Medical Student Education Clerkship

Marlene Kushner, C-TAGME
Program Coordinator, Radiation Oncology Medical Residency

Top Things to Do in Philadelphia in August 2019


Read More